Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New PowerViral™ Environmental RNA/DNA Isolation Kit

Published: Thursday, September 05, 2013
Last Updated: Wednesday, September 04, 2013
Bookmark and Share
New MO BIO kits for the extraction of viral and bacterial nucleic acids.

The new PowerViral™ Environmental RNA/DNA Isolation Kit is the latest addition to the MO BIO range of molecular biology tools, distributed exclusively in the UK by Cambio.

MO BIO’s kits specialize in nucleic acid extraction from difficult samples, and the new kit is no exception. It extracts viral and bacterial DNA and RNA from samples such as waste water, stool, biosolids and gut material.

The patented Inhibitor Removal Technology® (IRT) in the kit allows users to produce pure nucleic acids for use in downstream applications including PCR, cDNA synthesis and more.

IRT works by eliminating inhibitory substances, such as undigested plant material in the gut or heme compounds from lysed red blood cells, and produces high yields of exceptionally pure product.

PowerViral™ Environmental RNA/DNA Isolation Kits have the option of a bead beating protocol. Glass bead tubes, along with a strong chemical lysis buffer, provide optimal lysis of soil samples and bacterial cells.

The kits are also available without bead tubes for isolating viral nucleic acids from liquid samples, so researchers can extract using chemical lysis alone.

Cambio has been supplying molecular biology tools to the UK market from a global network of leading manufacturers for more than 25 years.

In order to provide the best possible service to its customers, Cambio is committed to supporting its constantly updating dynamic product line with competitive pricing and expert technical advice.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Cancer Related Immune Response Genes Uncovered
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer.
Deciphering Inactive X Chromosomes
Untangling the Barr body of inactive X chromosomes valuable for understanding chromosome structure and gene expression.
Micro Disease-Detecting Sensor Created
Researchers at McMaster University have created a microscopic disease-detecting sensor that can turn on to detect trace amounts of substances.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!